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ABSTRACT 
Background and Objectives: Diagnosis of Kawasaki disease (KD) is based on 5 clinical features. Incomplete KD 
(IKD), which has fewer features, is more common in infants and older children, in whom the rate of coronary ar-
tery aneurysms is paradoxically higher. We conducted this study to evaluate risk factors associated with age-at-diag-
nosis on coronary arterial lesions (CAL) in patients with IKD. Subjects and Methods: Retrospective data from 396 
patients with KD in a single center were collected from January 2003 to July 2007. Patients were grouped accord-
ing to their age at diagnosis; Group A (<1 year of age), Group B (1≤age<5 years of age), and Group C (≥5 years 
of age). Results: Among a total of 396 patients with KD, 87 (22.0%) were in Group A, 246 (62.1%) in Group B, 
and 63 (15.9%) in Group C. In groups A and C, lag times for starting intravenous immunoglobulin (IVIG) were 
longer than in Group B. There were no differences in the incidence of IKD, late CAL, or rates of IVIG retreat-
ment among the three groups. Among 174 patients with IKD, there were no age-related differences in late CAL 
incidence or IVIG retreatment. Compared with typical KD, duration of fever and lag times to start IVIG were long-
er, and the rate of IVIG retreatment was higher in IKD, but there was no difference in the risk of CAL between 
typical KD and IKD. Conclusion: In the management of KD, especially the incomplete type, age-associated fac-
tors appear not to be significant for predicting the development of CAL. (Korean Circ J 2010;40:283-287) 
 
KEY WORD: Mucocutaneous lymph node syndrome. 
 
 
Introduction 
 
Kawasaki disease (KD) is an acute febrile vasculitis of 
unknown etiology. It is a major cause of pediatric acquir-
ed heart diseases in Asia including South Korea.1-3) 
According to epidemiologic studies of KD in Korea 
from 2003 to 2005, 87.7% of cases occur in children un-
der 5 years of age . The peak age of onset was 6-12 months 
of age with the highest frequency being 13.9%.4) 
For children in the acute phase of KD, treatment with 
intravenous immunoglobulin (IVIG) and aspirin is still 
recommended by the American Heart Association (AHA). 
Approximately 15% to 25% of untreated children de-
velop coronary artery aneurysms or ectasia, but treat-
ment with IVIG in the acute phase reduces this risk to 
below 5%.5) Diagnosis of KD is based on 5 clinical fea-
tures. It can be difficult to diagnose because there is no 
unambiguous diagnostic laboratory test. Some patients 
who don’t fulfill the criteria have been diagnosed as hav-
ing “incomplete” KD, more frequently in infants and 
children older than 5 years of age, and diagnosis of KD 
might be delayed if there are fewer clinical features, which 
can lead to an increased incidence of coronary compli-
cations.6-10)  
In the present study, we evaluated and compared the 
prevalence, clinical features and time to start IVIG, and 
outcomes among different age groups, and analyzed age-
associated risk factors for coronary arterial lesions (CAL) 
in patients with incomplete KD (IKD). 
 
Subjects and Methods 
 
The charts of 396 inpatients diagnosed with KD at 
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Ajou University Hospital from January 2003 to July 2007 
were reviewed retrospectively.  
Clinical profiles, initial laboratory data, echocardio-
graphic findings, therapeutics and follow-up data in 
patients with KD were collected from each medical re-
cord. These patients were divided into 3 groups accord-
ing to the age at diagnosis: infants (Group A), children 
1 year of age or older but younger than 5 years of age 
(Group B), children 5 years-old or older (Group C).  
Diagnosis of KD was based on clinical features using 
the revised criteria of the AHA. This included fever for 
at least 4 days and an additional four of the following 
five signs: bilateral conjunctival injections; oral mucosal 
changes, such as injected pharynx, dry cracked lips, or 
strawberry tongue; changes in hands and feet, such as 
redness and swelling in the acute phase, and periungual 
desquamation in the subacute phase; rash, primarily on 
the trunk, that may be maculopapular, or erythema mul-
tiforme; and a cervical lymph node greater than 1.5 cm 
in diameter.5)6) Even if the aforementioned clinical crite-
ria were not satisfied, we included patients with dilatat-
ion or aneurysm of the coronary artery on echocardio-
graphy. Diagnosis of IKD was defined as unexplained 
fever for ≥4 days associated with 2 or 3 of the princi-
pal clinical features, or as unexplained fever for only a 
few days with 4 of the typical symptoms listed above, and 
exclusively other diseases.6)  
Echocardiograms were usually repeated on admission, 
again 2 months after the first echocardiogram, and th-
ereafter whenever necessary. Normal ranges for age-spe-
cific coronary artery size were used following the crite-
ria of the AHA.5) Based on these echocardiographic 
measurements of coronary arteries, cases were classified 
as abnormal when the internal lumen diameter was ≥3 
mm in children younger than 5 years of age or ≥4 mm 
in children aged 5 years or more, or when the internal 
diameter of any segment measured at least 1.5 times that 
of an adjacent segment, or when the coronary artery lu-
men was clearly irregular.7)  
Mean, SD and range were calculated for all descriptive 
variables. Nominal data were analyzed using the χ2 test. 
Continuous variables were compared using analysis of 
variance. P<0.05 was considered statistically significant. 
Analyses were done using Statistical Package for the So-
cial Sciences (SPSS) 13.0 (SPSS Inc, Chicago, IL, USA). 
 
Results 
 
Demographic characteristics and initial laboratory 
findings 
A total of 396 patients with KD and 174 with IKD 
were analyzed. The clinical profiles for the three groups 
are shown in Table 1. The number of males, 271 (69%), 
was greater than the number of females, 125 (31%), and 
the male-to-female ratio was 2.17 : 1. The mean age at 
diagnosis was 33.70±24.38 months (range: 2 months-
12 years).  
Eighty-seven (22.0%) were in Group A, 246 (62.1%) 
in Group B, and 63 (15.9%) in Group C. The mean age 
of each group was 7.23±2.49 months in Group A, 32.23 
Table 1. Demographic features and initial laboratory and outcome-related findings among the three age groups with Kawasaki disease
(KD) (n=396) 
 Total 
Group A 
(age<1 year) 
Group B 
(1≤age<5 years) 
Group C 
(age≥5 years) p
Number of patients (%) 396 (100) 0 87 (22.0) 246 (62.1) 63 (15.9) -
Age at KD diagnosis (month) 33.70±24.38 7.23±2.49 32.23±13.05 76.02±17.16 0.00
Male : Female ratio 2.17 : 1 2.35 : 1 2.00 : 1 2.70 : 1 0.58
Incomplete KD (no, %) 174 (43.9) 38 (51.4) 102 (48.1) 34 (64.7) 0.11
Initial laboratory findings      
Hemoglobin (g/dL) 
Hematocrit (%) 
WBC count (103/μL) 
Platelets (103/μL) 
Albumin (g/dL) 
CRP (mg/dL) 
11.52±1.25 
33.66±3.76 
14.13±6.45 
384.51±158.28 
3.87±0.45 
6.32±6.09 
11.16±1.31 
32.68±3.78 
15.01±6.00 
449.06±171.10 
3.89±0.41 
7.65±6.05 
11.59±1.25 
33.80±3.75 
14.00±6.35 
375.00±154.59 
3.89±0.47 
6.35±6.70 
11.78±1.10 
34.51±3.51 
13.31±7.26 
326.46±119.72 
3.79±0.47 
4.97±5.52 
0.01
0.01
0.28
0.00
0.34
0.05
Outcome-related findings      
Febrile duration (days) 4.88±2.03 4.80±2.39 4.92±1.94 4.83±1.90 0.88
Days before starting IVIG (days) 1.60±1.47 1.85±1.78 1.43±1.26 1.91±1.69 0.03
Initial CAL (no, %) 136 (34.3) 25 (28.7) 103 (41.9) 8 (12.7) 0.00
F/u 2 months CAL (no, %) 044 (11.1) 10 (11.8) 030 (12.9) 4 (6.6)0 0.39
IVIG retreated (no, %) 090 (22.7) 16 (21.7) 065 (30.8) 9 (16.9) 0.32
Add steroids after     
IVIG retreated (no, %) 028 (7.1)0 08 (10.8) 16 (7.5) 4 (7.5)0 0.67
Values in the table are mean±standard deviation. WBC: white blood cell, CRP: C-reactive protein, IVIG: intravenous immunoglobulin, CAL:
coronary arterial lesion, F/u: follow up 
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±13.05 months in Group B, and 76.02±17.16 months 
in Group C. Group A had significantly higher platelet 
counts and lower hemoglobin values than the other 
groups.  
The IKD group (n=174) accounted for 43.9% of total 
patients (n=396), with 38 (51.4%) in Group A, 102 
(48.1%) in Group B, and 34 (64.7%) in Group C. Groups 
A and C had relatively higher proportions of the in-
complete type than Group B (p=0.11).  
 
Response to treatment and development of coro-
nary arterial lesions 
Every patient with KD received high-dose IVIG treat-
ment or more. The mean lag time to start IVIG after 
admission was significantly longer in Groups A and C 
(1.85±1.78 days and 1.91±1.69 days, respectively) 
than in Group B (1.43±1.26 days). Initial echocardio-
graphy findings indicated that there was a higher incid-
ence of CAL in the 103 patients (41.9%) in Group B. 
After 2 months, there were no significant differences 
among the 3 groups.  
There were no significant differences among the 3 age 
groups with regard to the necessity for IVIG retreatment 
or additional dexamethasone (Table 1).  
 
Clinical features and outcomes in patients with in-
complete Kawasaki disease  
Comparisons of clinical features among the 3 age gr-
oups with IKD are shown in Table 2. The male-to-female 
ratio was 2.0 : 1. The mean age at diagnosis was 35.14± 
25.11 months.  
The lag time to start IVIG after admission were re-
latively longer in Groups A and C than Group B (p= 
0.29). Duration of fever, however, was not different among 
the 3 groups.  
On initial echocardiography, there was a higher incid-
ence of CAL (n=43, 42.2%) in Group B. After 2 months, 
there were no significant differences among the 3 groups. 
There were no significant differences among the 3 groups 
with regard to the need for IVIG retreatment or for ad-
ditional dexamethasone (Table 2).  
Comparisons among the 3 IKD groups with regard to 
common clinical features are described in Table 3. Most 
common symptoms in the 3 IKD groups were bilateral 
conjunctival injection (38% in Group A), red lip/oral 
mucosal changes (38.3% in Group B), and cervical lym-
phadenopathy (34.4% in Group C).  
 
Age-specific comparisons of clinical features and 
outcomes between patients with typical Kawasaki 
disease and those with incomplete Kawasaki 
disease 
Compared with typical KD, the duration of fever was 
longer in IKD Group A, but there were no significant 
differences for other parameters.  
In IKD Group B, the duration of fever and lag time 
to start IVIG after admission were longer and the rate 
of IVIG retreatment higher than those with typical KD. 
There were no differences in CAL between KD and 
IKD groups (Table 2).  
Table 2. Clinical features and outcomes among the three age groups with incomplete Kawasaki disease (IKD) (n=174) 
 Total 
Group A 
(age<1 year) 
Group B 
(1≤age<5 years) 
Group C 
(age≥5 years) p
Number of IKD patients (%) 174 (100) 38 (21.8) 102 (58.7) 34 (19.5) 0.11
Age at KD diagnosis (months) 35.14±25.11 7.39±2.55 32.24±13.40 74.88±14.43* 0.00
Male : Female ratio 2.00 : 1 1.53 : 1* 1.91 : 1 3.25 : 1 0.34
Outcome-related findings     
Febrile duration (days) 5.11±2.26 5.39±2.71* 5.22±2.23* 4.50±1.71 0.19
Days to start IVIG (days) 1.78±1.64 2.03±1.78 1.62±1.55* 2.00±1.74 0.29
Initial CAL (no, %) 59 (33.9) 10 (26.3) 43 (42.2) 6 (17.6) 0.02
F/u 2 months CAL (no, %) 27 (16.4) 07 (18.4) 16 (16.8) 4 (12.5) 0.79
IVIG retreated (no, %) 46 (26.6) 10 (26.2) 027 (26.7)* 9 (26.5) 0.63
Added steroids after     
IVIG retreatment (no, %) 13 (7.5)0 05 (13.2) 06 (5.9) 2 (5.9)0 0.32
Mean±standard deviation. *There were significant differences between complete and incomplete KD (p<0.05). WBC: white blood cell, CRP: C-
reactive protein, IVIG: intravenous immunoglobulin, CAL: coronary arterial lesion 
 
Table 3. Most common symptoms in incomplete Kawasaki disease among the three age groups
Order of frequency 
Group A (%) 
n=38 
Group B (%) 
n=102 
Group C (%) 
n=34 
Most common Conjunctival injection (38.0) Oral mucosal changes (38.3) Cervical lymphadenopathy (34.4)
2nd most common Polymorphous skin rash (20.1) Conjunctival injection (26.9) Conjunctival injection (24.6) 
3rd most common Oral mucosal changes (18.3) Polymorphous skin rash (16.1) Oral mucosal changes (18.9) 
4th most common Change of extremities (14.6) Cervical lymphadenopathy (11.3) Polymorphous skin rash (16.3) 
5th most common Cervical lymphadenopathy (8.9) Changes in the extremities (7.7) Changes in the extremities (5.8)
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 Discussion 
 
KD is an acute febrile vasculitis of unknown etiology 
that commonly affects children under 5 years of age. 
Since first reported by Tomisaku Kawasaki10) in 1967, 
it has been the most common acquired cardiovascular 
disease among pediatric patients. In 1984, Furusho et 
al.11) reported the effects of IVIG therapy on KD, and 
the occurrence of CAL and its mortality were significantly 
reduced.  
Whereas children with the typical KD are immedi-
ately diagnosed and given IVIG treatment after admis-
sion, however, children with IKD are difficult to disting-
uish from children with other infectious diseases and 
the time required to find clear diagnostic criteria often 
results in delayed treatment of KD.12) There was a great-
er time interval from meeting the diagnostic criteria to 
making the diagnosis, and a higher proportion of CAL 
in infants under 1 year of age and children over 5 years 
of age compared with children 1 to 5 years of age.13-15)  
The Kawasaki Disease Research Committee publish-
ed a set of revised diagnostic criteria in 2002.5)6) Major al-
terations were interpretation of cases with 4 or fewer 
febrile days shortened by early IVIG treatment and the 
importance of IKD. Then, the AHA published the latest 
set of diagnostic criteria and the importance of IKD was 
emphasized. Conventional diagnostic criteria should be 
viewed as guidelines that are particularly useful in pre-
venting over-diagnosis, but may also result in failure to 
recognize incomplete forms of the illness. In the present 
study, according to the revised guidelines of the AHA, 
children under the age of 1 year and over 5 years with 
IKD have a higher incidence (51.4% and 64.7%, res-
pectively) compared with KD (22.0% and 15.9%, respec-
tively). Moreover, time to start IVIG treatment after ad-
mission was significantly longer in both younger and 
older IKD groups than in children 1 to 5 years of age. 
Since there is a possibility of delayed treatment in both 
groups, the risk of CAL accompanying IKD may be in-
creased. In our study, however, there was no significant 
difference among the 3 groups between KD and IKD.  
Even if a patient has only a few KD symptoms, sug-
gesting IKD, early diagnosis of KD can be achieved th-
rough common clinical manifestations that distinguish 
among the 3 groups by age.  
Hsiao et al.13) reported that patients less than 6 months 
of age with oral lesions or hard swelling of the palms or 
feet, are rare. Typical mucosal changes and enlarged lym-
ph nodes in patients less than 6 months old are less likely. 
Fan et al.14) reported that cervical lymph node enlarge-
ment appeared in most school children with KD who 
were diagnosed early with acute purulent lymph nodes 
and treated with antibiotic treatment. In our study of 
IKD, bilateral conjunctival injection was the most com-
mon presentation of diagnostic criteria in infants and 
cervical lymphadenopathy in patients older than 5 years.  
Recent studies of vascular function in KD have fo-
cused on endothelial dysfunction and the progressive 
atherosclerosis after the onset of KD. They suggest that 
there are no significant differences between normal co-
ronary arteries of well-treated KD patients and healthy 
people.8)16)17) Even in KD patients with good responses 
to IVIG, CAL still occasionally occurs.18-21) High echo-
density of the coronary arterial wall was demonstrated 
at a mean of 5.4 days from onset. Without IVIG thera-
py, diffuse coronary artery dilatation was observed in 
50% of KD patients at about 9.5 days after onset of symp-
toms, diffuse coronary artery dilatation progresses to an-
eurysms in 28.8% by 11.4 days, and resolution of coro-
nary artery dilatation occurs within 30 days of onset of 
transient dilation. CALs that persist beyond 30 days from 
onset might be considered KD sequelae.8)15) CALs of small 
to medium size are likely to regress within 1 to 2 years but 
still remain in 3-7% after the onset of KD.15) 20)21) There-
fore, serial echocardiographic studies should be perform-
ed to evaluate CAL.  
We found that children older than 5 years of age as 
well as those younger than 1 year of age have a higher per-
centage of IKD, and there were no significant differ-
ences in clinical outcomes: whether re-treatment was 
needed or not, and whether there is advanced develop-
ment of late CAL. Prolonged fever without any defi-
nite association with conjunctival injection in children 
younger than 1 year of age and cervical lymphadeno-
pathy in children older than 5 years of age should be con-
sidered as diagnostic for KD. Recently in the manage-
ment of KD, especially IKD, age at diagnosis may be no 
more significant to determine the development of CAL. 
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